Li Shiyu, Yi Ming, Dong Bing, Jiao Ying, Luo Suxia, Wu Kongming
Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
Clin Transl Med. 2020 Dec;10(8):e257. doi: 10.1002/ctm2.257.
Exosomes are a category of extracellular vesicles with a size ranging from 40 to 160 nm, which can be secreted by multiple cells in the tumor microenvironment. Exosomes serve as communicators in regulating biological functions and pathological processes, including drug response. Through transporting the cargo such as protein or nucleic acid, exosomes can modulate drug sensitivity via multiple mechanisms. Additionally, exosomes can be deployed as a delivery system to treat cancer due to their high-efficient loading capacity and tolerable toxicity. Recent studies have demonstrated the high efficacy of exosomes in cancer therapy. Herein, we conduct this review to summarize the mechanism of exosome-mediated drug resistance and the therapeutic potential of exosomes in cancer.
外泌体是一类细胞外囊泡,大小在40到160纳米之间,可由肿瘤微环境中的多种细胞分泌。外泌体在调节生物功能和病理过程(包括药物反应)中充当通讯者。通过运输蛋白质或核酸等货物,外泌体可通过多种机制调节药物敏感性。此外,由于外泌体具有高效的负载能力和可耐受的毒性,它们可被用作治疗癌症的递送系统。最近的研究表明外泌体在癌症治疗中具有很高的疗效。在此,我们进行本综述以总结外泌体介导的耐药机制以及外泌体在癌症治疗中的潜在应用。